CoChat
Sign Up
Cited by 9Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsMaternal and Neonatal Healthcare

Gestational diabetes in Turkmenistan: Implementation of a screening program and first results

Parhofer, K. G., Hasbargen, U., Ulugberdiyewa, A., Abdullayewa, M., Melebayewa, B., Annamuhammedov, A., Gaipow, M., Atabayeva, O. +1 more·2014·Archives of Gynecology and Obstetrics
DOI 10.1007/s00404-013-2961-2
Open this paper in CoChat — free account

Abstract

Purpose Data on the prevalence of gestational diabetes (GDM) is not available for Turkmenistan or any other central Asian country with large energy resources and rapidly increasing wealth and rates of obesity. We initiated a screening program to determine the prevalence of and the risk factors for GDM in Turkmenistan. Methods Between March 2008 and March 2011, all pregnant women presenting to the Ene-Maehri-Merkezi perinatal center in Ashgabat before week 34 of pregnancy received a glucose screening test (after 26 weeks of pregnancy; 50 g glucose). If 60-min glucose was ≥7.8 mmol/l, an oral glucose tolerance test (oGTT) (75gr) was performed. GDM was diagnosed if ≥1 glucose values were abnormal (≥5.0, ≥10.0, ≥8.0 mmol/l at 0-, 60-, 120-min, respectively). Birth weight, 30 min glucose, and APGAR (1, 5, and 10 min) were recorded for all newborns. Results Of 1,738 women, 22.7 % had a pathological screening test. 70 % of these, underwent an oGTT and of these, 39.5 % had GDM (overall prevalence 6.3 %). Age, BMI, parity, and blood pressure were associated with screening glucose (all p < 0.001). In a multivariate analysis, age, BMI, and family history for diabetes were associated with GDM. Newborns from affected mothers were heavier (3,622 ± 435 vs. 3,480 ± 464 g, p = 0.007) and developed postnatal hypoglycaemia more often (21.6 vs. 9.3 %, p = 0.001), while there was no difference in APGAR. Conclusions GDM is a relevant problem in Turkmenistan and probably also in other central Asian countries. The prevalence is similar to other developing countries such as India or China. Risk factors are comparable to those determined in other parts of the world.

Integrity signals

Registry

Crossref · 10.1007/s00404-013-2961-2

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Turkmenistan, between March 2008 and March 2011, Parhofer et al. conducted a screening program with 1738 pregnant women at 34 weeks using 50 g GCT; positive screening test was confirmed in 22.7% of patients, 70% underwent OGTT, 39.5% were diagnosed with GDM, and overall prevalence was 6.3%.

    “A positive screening test was confirmed in 22.7% of the patients. A total of 70 % of them underwent an OGTT test, and 39.5% of the women were diagnosed with GDM. The overall prevalence was assessed at 6.3% [206].”

    From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [206]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Parhofer, K. G., Hasbargen, U., Ulugberdiyewa, A., Abdullayewa, M., Melebayewa, B., Annamuhammedov, A., Gaipow, M., Atabayeva, O., & Flemmer, A. W.
Affiliations
Ludwig-Maximilians-Universität München (DE)
Corresponding author
Parhofer, K. G.
ORCID
Venue
Archives of Gynecology and Obstetrics
Publisher
Springer Science and Business Media LLC
Published
2013-07-19
Volume
289
Issue
2
Pages
293-298
ISSN
  • 0003-9128 (ISSN-L)
  • 0932-0067
  • 1432-0711
DOI
10.1007/s00404-013-2961-2
OpenAlex
W2089347905
Cited by
9
References
30
Citations by year
2024: 1 · 2023: 1 · 2022: 3 · 2018: 3 · 2013: 1
FWCI
0.37
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Archives of Gynecology and Obstetrics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Health Professions › General Health Professions › Maternal and Neonatal Healthcare
Keywords
gestational diabetes mellitus, prevalence, risk factors, screening programs, oral glucose tolerance test, newborn birth weight, maternal obesity, family history of diabetes, Turkmenistan, Central Asia
MeSH terms
Adult, Apgar Score, Birth Weight, Blood Glucose, Developing Countries, Female, Glucose Tolerance Test, Humans, Infant, Newborn, Mass Screening, Maternal Age, Parity, Pregnancy, Risk Factors, Turkmenistan, Body Mass Index, Prevalence, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review